nedaplatin has been researched along with Hematologic Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, YH; Li, QQ; Liu, MZ; Wang, QX; Wang, XH; Xiao, WW; Yang, H; Zhang, WW; Zhu, YJ | 1 |
Fujita, S; Fukuhara, A; Hatachi, Y; Irisa, K; Kim, YH; Masago, K; Mio, T; Mishima, M; Nagai, H; Sakamori, Y; Togashi, Y | 1 |
Furuta, I; Kurashina, K; Kurita, H; Nozaki, S; Wada, S; Yamamoto, E | 1 |
Hojo, K; Maekawa, R; Sugita, K; Takeda, Y; Uchida, N; Yoshioka, T | 1 |
2 trial(s) available for nedaplatin and Hematologic Diseases
Article | Year |
---|---|
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Squamous Cell; Organoplatinum Compounds; Survival Analysis; Treatment Outcome | 2011 |
Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Remission Induction; Taxoids; Treatment Outcome | 2004 |
2 other study(ies) available for nedaplatin and Hematologic Diseases
Article | Year |
---|---|
Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Dose-Response Relationship, Drug; Female; Fluorouracil; Hematologic Diseases; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organoplatinum Compounds | 1998 |